Metabolic dysfunction-associated steatohepatitis (MASH): Difference between revisions
| Line 21: | Line 21: | ||
*[[LFTs]], CBC | *[[LFTs]], CBC | ||
*[[RUQ US]] | *[[RUQ US]] | ||
*Outpatient elastography/Fibroscan | |||
==Management== | ==Management== | ||
Revision as of 07:09, 18 August 2022
Background
- Fatty liver disease due to causes other than excessive alcohol
- Associated with insulin resistance and metabolic syndrome
Clinical Features
- Often asymptomatic or with mild RUQ discomfort
- Signs of portal hypertension (e.g. ascites) if advanced fibrosis
- Hepatomegaly
Differential Diagnosis
- Cirrhosis
- Hepatitis
- Viral hepatitis
- Autoimmune hepatitis
- Wilson's disease
- Hemochromatosis
- Hepatocellular carcinoma
- CHF (right heart failure]]
Evaluation
Management
- Treat complications of portal hypertension, if present
Disposition
- Discharge unless complications